Predictors of outcome in Cryptococcus neoformans var. gattii meningitis

QJM: An International Journal of Medicine

Volumn 89, Issue 6, 1996, Pages 423-428

  Seaton, R A ^a,b,c   Naraqi, S ^b   Wembri, J P ^b   Warrell, D A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF PAPUA NEW GUINEA   (Papua New Guinea)

^c King's Cross Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCYTOSINE; FUNGUS ANTIGEN; MARKER;

ADOLESCENT; ADULT; AGE; ARTICLE; BRAIN HERNIA; CEREBROSPINAL FLUID PRESSURE; CONSCIOUSNESS DISORDER; CONVULSION; CRYPTOCOCCUS NEOFORMANS; FEMALE; FUNGAL MENINGITIS; HUMAN; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL DRUG ADMINISTRATION; PAPUA NEW GUINEA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0029949313     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.6.423     Document Type: Article

References (18)

1. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123-30.
2. Collins VP, Gelhorn A, Trimble JR. Coincidence of cryptococcosis and disease of reticuloendothelial and lymphatic systems. Cancer 1951; 4: 883.
3. Schroter GPJ, Temple DR, Husberg BS, Weil R, Starzl TE. Cryptococcosis after renal transplantation: Report of ten cases. Surgery 1976; 79(3): 268-77.
4. Kaplan MH, Rosen PP, Armstrong D. Cryptococcosis in a cancer hospital. Cancer 1977; 39: 2265-74.
5. Kovacs JA, Kovas AA, Polis M, Wright C, Gill VJ, Tuazon CU, Gelmann EP, Lane HC, Longfield R, Overturf G, Macher AM, Fauci AS, Parrillo JE, Bennett JE, Masur H. Cryptococcosis in the Acquired Immunodeficiency Syndrome. Ann Intern Med. 1985; 103: 533-8.
6. Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum, Richards MJ, Gottlieb T. Cryptococcal disease of the CNS in Immunocompetent Hosts: Influence of Cryptococcal variety on Clinical Manifestations and Outcome. Clin Infect Dis 1995; 20: 611-16.
7. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 21: 28-34.
8. Rozenbaum R, Goncalves JR. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 1994; 18: 369-80.
9. Lalloo D, Fisher D, Naraqi S, Laurenson I, Temu P, Sinha A, Saweri A, Mavo B. Cryptococcal meningitis (C. neoformans var. gattit) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. Q J Med 1994; 87: 343-9.
10. Seaton RA, Verma N, Naraqi S, Wembri J. Ocular manifestations of Cryptococcus neoformans var. gattii meningitis in immunocompetent patients. 1. Predictors of visual loss (submitted).
11. Seaton RA, Verma N, Naraqi S, Wembri J. Ocular manifestations of cryptococcal meningitis in immunocompetent patients. 2. Effect of corticosteroids (submitted).
12. Kwon-Chung KJ, Polacheck I, Bennet JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982; 15: 535-7.
13. Saag MS, Powderly WC, Cloud GA, Robinson P, Grieco MH, Sharkey PK, Thompson SE, Sugar AM, Tuazon CU, Fisher JF, Hyslop N, Jacobson JM, Hafner R, Graybill JR, Dismukes WE, and the NIAD mycoses study group and the AIDS clinical trials group. Comparison of amphotericin B with fluconazole in the treatment of acute AIDs associated cryptococcal meningitis. N Engl J Med 1992; 326: 83-9.
14. Tjia TL, Yeow YK, Tan CB. Cryptococcal meningitis. J Neurol Neurosurg Psychiatr 1985; 48: 853-8.
15. Diamond RD, Bennett JE. Prognostic factors in cryptococcal meningitis. Ann Intern Med 1974; 80: 176-81.
16. Zuger A, Louie E, Holzman RS, Simberkoff MS, Rahal JJ. Cryptococcal disease in patients with the Acquired Immunodeficiency syndrome. Ann Intern Med 1986; 104: 234-40.
17. Spitzer ED, Spitzer SG, Freundlich LF, Casadevall A. Persistence of initial infection in recurrent Cryptococcus neoformans meningitis. Lancet 1993; 341: 595-6.
18. Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: Value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis 1994; 18: 789-92.